von Willebrand Factor and Its Propeptide in Children with Diabetes. Relation between Endothelial Dysfunction and Microalbuminuria

It has been shown that patients with insulin-dependent diabetes mellitus have elevated von Willebrand factor (vWF) plasma concentrations. Plasma fibrinogen, vWF, and its propeptide concentrations have been evaluated in 102 children with insulin-dependent diabetes mellitus to determine whether an increase of vWF and its propeptide levels precedes and may predict the development of persistent microalbuminuria. The patients have been divided into two groups according to the presence or absence of microalbuminuria at the end of follow-up. They have been followed up for at least 8 y. Control group consisted of 80 age- and sex-matched healthy volunteers. At the beginning of the study there was no significant difference in fibrinogen, vWF, and its propeptide levels between patients and control subjects. During the follow-up, a significant increase of plasma vWF and its propeptide has been observed in the group of patients who later developed microalbuminuria but not in those who remained normoalbuminuric. This increase started 3 y and become statistically significant (p < 0.01) 2 y before the onset of microalbuminuria, persisting until the end of the study. During the entire follow-up plasma values of fibrinogen persisted in the normal range. In conclusion, an increase in plasma concentration of vWF and its propeptide precedes microalbuminuria and, therefore, can be useful to identify children with insulin-dependent diabetes mellitus at risk to develop incipient nephropathy later in life.

[1]  J. Stephenson,et al.  Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM complications study , 1997, Diabetologia.

[2]  J. Leach,et al.  Plasma Endothelinlike Immunoreactivity Levels in IDDM Patients with Microalbuminuria , 1992, Diabetes Care.

[3]  C. Stehouwer,et al.  von Willebrand Factor (vWf) as a Plasma Marker of Endothelial Activation in Diabetes: Improved Reliability with Parallel Determination of the vWf Propeptide (vWf:AgII) , 1998, Thrombosis and Haemostasis.

[4]  J. Vane,et al.  Regulatory functions of the vascular endothelium. , 1990, The New England journal of medicine.

[5]  T. Jensen.  Albuminuria--a marker of renal and generalized vascular disease in insulin-dependent diabetes mellitus. , 1991, Danish medical bulletin.

[6]  H. Parving.  Microalbuminuria in essential hypertension and diabetes mellitus , 1996, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[7]  G. Remuzzi,et al.  Endothelins in the control of cardiovascular and renal function , 1993, The Lancet.

[8]  A. Donker,et al.  Endothelial Dysfunction Precedes Development of Microalbuminuria in IDDM , 1995, Diabetes.

[9]  H. Schouten,et al.  Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions. , 1999, Diabetes.

[10]  B. Feldt-Rasmussen,et al.  FEATURES OF ENDOTHELIAL DYSFUNCTION IN EARLY DIABETIC NEPHROPATHY , 1989, The Lancet.

[11]  G. Pagano,et al.  PAI-1 and Factor VII Activity Are Higher in IDDM Patients With Microalbuminuria , 1994, Diabetes.

[12]  K. Borch-Johnsen,et al.  Aspects of haemostatic function in healthy subjects with microalbuminuria--a potential atherosclerotic risk factor. , 1995, Thrombosis research.

[13]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[14]  G. Crepaldi,et al.  (EURODIAB IDDM) Complications Study Group: Prevalence and management of hypertension in Type 1 diabetes mellitus in Europe. , 1999 .

[15]  K. Borch-Johnsen,et al.  Albuminuria reflects widespread vascular damage , 1989, Diabetologia.

[16]  B. Feldt-Rasmussen,et al.  Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. , 1985, Scandinavian journal of clinical and laboratory investigation.

[17]  A. Donker,et al.  Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus , 1992, The Lancet.

[18]  G. Dell'omo,et al.  Microalbuminuria and endothelial dysfunction in essential hypertension , 1994, The Lancet.

[19]  I. Ford,et al.  Relationships between Haemostatic Factors and Capillary Morphology in Human Diabetic Neuropathy , 1992, Thrombosis and Haemostasis.

[20]  C. Stehouwer,et al.  Von Willebrand Factor and Development of Diabetic Nephropathy in IDDM , 1991, Diabetes.

[21]  R J Jarrett,et al.  Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. , 1992, Kidney international.

[22]  P. Groop,et al.  Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. , 1993, Clinical science.

[23]  T. Deckert,et al.  Endothelial function and serum lipids in the course of developing microalbuminuria in insulin-dependent diabetes mellitus. , 1994, Diabetes research.

[24]  M. Limburg,et al.  PREDISPOSITION FOR ATOPY OR ALLERGY LINKED TO HL-A , 1975, The Lancet.

[25]  W. Haefeli,et al.  Acute von Willebrand Factor Secretion from the Endothelium In Vivo: Assessment through Plasma Propeptide (vWf:AgII) Levels , 1997, Thrombosis and Haemostasis.

[26]  H. Keen,et al.  URINARY ALBUMIN EXCRETION AND DIABETES MELLITUS. , 1964, Lancet.